FRHC:NASDAQFreedom Holding Corp. Analysis
Data as of 2026-06-22 - not real-time
$143.70
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Freedom Holding Corp. reported a fiscal‑year net income of $153.3 million, more than double the prior year’s $76.2 million, driven by a 9 % rise in revenue to a record $2.19 billion. The top‑line expansion lifted the trailing EPS to $2.50 and the forward EPS outlook to $4.50, indicating accelerating profitability. Gross margins remain robust at roughly 82 %, but operating margins are still slightly negative, reflecting ongoing investment in the banking and insurance segments. The company sits on a strong cash balance of $3.3 billion while carrying $2.43 billion of debt, resulting in a high debt‑to‑equity ratio that warrants monitoring. Valuation metrics are stretched: the current price of $143.7 trades at a forward P/E of about 32 versus an industry average of 17, and the DCF‑derived fair value of $90 suggests the stock is markedly overvalued. Technical indicators show a neutral trend with the 20‑day SMA just above the 50‑day SMA, but the MACD histogram is negative and the signal line is bearish, hinting at short‑term downside pressure.
RSI sits near 50, offering no clear overbought or oversold signal, while 30‑day volatility is elevated at roughly 44 % and beta exceeds 1, underscoring heightened market sensitivity. The stock’s support level sits near $133 and resistance near $161, placing the current price within a narrow range that could be tested in the coming weeks. With no dividend and a payout ratio of zero, income‑focused investors have limited yield appeal. Nevertheless, the diversified business model across brokerage, banking, insurance, and technology provides multiple growth levers, especially in emerging markets such as Kazakhstan. The company’s strong cash flow generation and expanding international footprint mitigate some of the valuation concerns over the longer horizon. Given the blend of strong earnings momentum, high valuation, and bearish short‑term technicals, an cautious stance is warranted.
RSI sits near 50, offering no clear overbought or oversold signal, while 30‑day volatility is elevated at roughly 44 % and beta exceeds 1, underscoring heightened market sensitivity. The stock’s support level sits near $133 and resistance near $161, placing the current price within a narrow range that could be tested in the coming weeks. With no dividend and a payout ratio of zero, income‑focused investors have limited yield appeal. Nevertheless, the diversified business model across brokerage, banking, insurance, and technology provides multiple growth levers, especially in emerging markets such as Kazakhstan. The company’s strong cash flow generation and expanding international footprint mitigate some of the valuation concerns over the longer horizon. Given the blend of strong earnings momentum, high valuation, and bearish short‑term technicals, an cautious stance is warranted.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price well above DCF fair value
- bearish MACD signal
- elevated volatility and beta
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- double‑digit revenue growth
- high debt‑to‑equity ratio
- still elevated valuation
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- diversified multi‑segment model
- strong cash position
- expanding presence in high‑growth markets
Key Metrics & Analysis
Financial Health
Revenue Growth146.70%
Profit Margin9.38%
P/E Ratio57.5
ROE11.30%
ROA1.33%
Debt/Equity163.28
P/B Ratio5.9
Op. Cash Flow$185.2M
Industry P/E16.9
Technical Analysis
TrendNeutral
RSI50.4
Support$133.00
Resistance$160.71
MA 20$144.41
MA 50$146.49
MA 200$142.77
MACDBearish
VolumeStable
Fear & Greed Index90.25
Valuation
Fair Value$90.43
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.11
Volatility43.99%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.